Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.88−0.08 (-8.24%)
Close on Nov 16, 2026Market cap $13.93MP/E –Yield –
Allarity Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Allarity Therapeutics's enterprise value was $18.76M on Nov 11, 2026, against $4.53M a year earlier. Over the last 5 years it ranged from -$15.47M to $2.01T, with a median of $26.21M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $18.76M | +3612.3% |
| 2025 | Dec 31, 2025 | $505.38K | – |
| 2024 | Dec 31, 2024 | -$15.27M | -101.1% |
| 2023 | Dec 29, 2023 | $1.38B | -98.1% |
| 2022 | Dec 30, 2022 | $72.35B | -96.4% |
| 2021 | Dec 31, 2021 | $2.01T | – |
See a number that looks wrong?